The U.S. Senate is in session for three days this week while the U.S. House of Representatives is in recess all week. Both chambers will return for a week before breaking for the July 4 recess. Negotiations on the...more
6/18/2025
/ Budget Reconciliation ,
Congressional Committees ,
Congressional Investigations & Hearings ,
Department of Health and Human Services (HHS) ,
Executive Orders ,
Food and Drug Administration (FDA) ,
Healthcare ,
Healthcare Reform ,
Medicaid ,
Medical Research ,
Medicare ,
MedPAC ,
National Institute of Health (NIH) ,
Proposed Legislation
In a surprising move, the U.S. Department of Health and Human Services (HHS) announced it is reconstituting the Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP), removing...more
6/12/2025
/ ACIP ,
Administrative Procedure Act ,
Advisory Committee ,
Centers for Disease Control and Prevention (CDC) ,
Department of Health and Human Services (HHS) ,
Health Insurance ,
Healthcare ,
Healthcare Reform ,
Medicaid ,
Medicare ,
Medicare Part D ,
Public Health ,
Vaccinations
Following the announcement that four Center for Medicare and Medicaid Innovation (CMMI or Innovation Center) models will end in 2025, the Centers for Medicare & Medicaid Services (CMS) has begun signaling what's next for the...more
5/20/2025
/ Centers for Medicare & Medicaid Services (CMS) ,
CMMI ,
Drug Pricing ,
Healthcare Reform ,
Innovation ,
Medicaid ,
Medicare ,
Medicare Advantage ,
Physicians ,
Risk Management ,
Value-Based Care
President Donald Trump on May 12, 2025, issued an executive order (EO) titled "Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients" and an accompanying Fact Sheet, "President Donald J. Trump...more
5/15/2025
/ Commerce Clause ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Executive Orders ,
Imports ,
Inflation Reduction Act (IRA) ,
Medicaid ,
Medicare ,
Most-Favored Nations ,
Pharmaceutical Industry ,
Trump Administration ,
U.S. Commerce Department ,
USTR
The Center for Medicare and Medicaid Innovation (CMMI) has released a statement on plans to unveil a new strategy focused on "improving the health of Americans through disease prevention via evidence-based practices,...more
3/19/2025
/ ACOs ,
Centers for Medicare & Medicaid Services (CMS) ,
CMMI ,
Department of Health and Human Services (HHS) ,
Health Care Providers ,
Healthcare ,
Healthcare Reform ,
Medicaid ,
Medicare ,
Trump Administration ,
Value-Based Care
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more
2/20/2025
/ Artificial Intelligence ,
Centers for Medicare & Medicaid Services (CMS) ,
Controlled Substances ,
DEA ,
Department of Health and Human Services (HHS) ,
Federal Budget ,
Health Insurance ,
Healthcare ,
Healthcare Reform ,
Legislative Agendas ,
Medicaid ,
Medicare ,
Pharmaceutical Industry ,
Public Health ,
Regulatory Agenda ,
Senate Confirmation Hearings
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
This week's topics include ...more
1/17/2025
/ Congressional Committees ,
Congressional Intent ,
Department of Health and Human Services (HHS) ,
Federal Funding ,
Health Care Providers ,
Health Insurance ,
Healthcare ,
Healthcare Reform ,
Legislative Agendas ,
Medicaid ,
Medicare ,
New Legislation ,
Regulatory Agenda ,
Trump Administration
Holland & Knight's Healthcare & Life Sciences Policy Team regularly provides updates through our weekly Health Dose. This special Health Dose: Post-Election Edition is intended to outline the short- and long-term potential...more
11/12/2024
/ Affordable Care Act ,
Centers for Medicare & Medicaid Services (CMS) ,
Congressional Committees ,
Congressional Intent ,
Election Results ,
Federal Budget ,
General Elections ,
Health Care Providers ,
Healthcare Reform ,
Legislative Agendas ,
Medicaid ,
Medicare ,
NDAA ,
Political Parties ,
Presidential Elections ,
Public Policy
The Centers for Medicare & Medicaid Services (CMS) on Sept. 20, 2024, released the Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program (CMS-2434) Final Rule....more
The Centers for Medicare & Medicaid Services (CMS) issued the CMS Interoperability and Prior Authorization Final Rule (Final Rule) on Jan. 17, 2024. The agency proposed the rule in December 2022 (See Holland & Knight's...more
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more
12/15/2023
/ Biden Administration ,
Centers for Medicare & Medicaid Services (CMS) ,
Congressional Committees ,
Cybersecurity ,
Drug Pricing ,
Federal Funding ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Interim Final Rules (IFR) ,
Medicaid ,
Medicare ,
Medicare Part B ,
MedPAC ,
OMB ,
Pending Legislation ,
Pharmacy Benefit Manager (PBM) ,
Prescription Drugs ,
Private Equity ,
Private Equity Firms ,
Resignation ,
Transparency
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
...more
10/4/2023
/ Appropriations Bill ,
Biden Administration ,
CBO Report ,
Centers for Disease Control and Prevention (CDC) ,
CMMI ,
Congressional Committees ,
Continuing Resolution ,
Drug Pricing ,
Federal Budget ,
HSA ,
Legislative Agendas ,
Managed Care Contracts ,
Medicaid ,
Medicare ,
National Institute of Health (NIH) ,
Pharmacy Benefit Manager (PBM) ,
Reporting Requirements ,
Request For Information
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more
9/14/2023
/ Anti-Discrimination Policies ,
Artificial Intelligence ,
Centers for Medicare & Medicaid Services (CMS) ,
CMMI ,
Congressional Investigations & Hearings ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Federal Budget ,
Health Care Providers ,
Information Reports ,
Long Term Care Facilities ,
Medicaid ,
Medicare ,
Medicare Part B ,
Nurses ,
Pharmacy Benefit Manager (PBM) ,
PHI ,
Prescription Drugs ,
Proposed Rules ,
Transparency
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
...more
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
...more
6/5/2023
/ CBO Report ,
Centers for Medicare & Medicaid Services (CMS) ,
Congressional Committees ,
Congressional Investigations & Hearings ,
Health Care Providers ,
Health Insurance ,
Medicaid ,
Medicaid Drug Rebate Program ,
Pharmacy Benefit Manager (PBM) ,
Proposed Legislation ,
Public Health Emergency
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
This week's topics include...more
5/25/2023
/ Biden Administration ,
Comment Period ,
Congressional Committees ,
Debt Ceiling ,
Federal Budget ,
Federal Trade Commission (FTC) ,
GAO ,
Health Care Providers ,
Health Insurance Portability and Accountability Act (HIPAA) ,
HIPAA Breach Notification Rule ,
Medicaid ,
Mental Health ,
PHI ,
Proposed Legislation ,
Section 340B ,
Telehealth
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
...more
5/19/2023
/ Centers for Medicare & Medicaid Services (CMS) ,
Children's Health Insurance Program (CHIP) ,
Congressional Committees ,
Coronavirus/COVID-19 ,
Debt Ceiling ,
Drug Pricing ,
Federal Budget ,
GAO ,
Generic Drugs ,
Medicaid ,
Medicare ,
Pharmacy Benefit Manager (PBM) ,
Prescription Drugs ,
Proposed Legislation ,
Public Health Emergency ,
Section 340B
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
This week's topics include...more
5/4/2023
/ Centers for Medicare & Medicaid Services (CMS) ,
Children's Health Insurance Program (CHIP) ,
Congressional Committees ,
Congressional Investigations & Hearings ,
Drug Pricing ,
Health Care Providers ,
Hospitals ,
Inflation Reduction Act (IRA) ,
Medicaid ,
Prescription Drugs ,
Proposed Legislation ,
Tax Exempt Entities ,
Transparency
The Biden Administration announced on Jan. 30, 2023, its intent to end the COVID-19 Public Health Emergency (PHE) on May 11, 2023. Fortunately, the 2023 Consolidated Appropriations Act (CAA) extends certain key telehealth...more
5/2/2023
/ Biden Administration ,
CARES Act ,
Consolidated Appropriations Act (CAA) ,
Coronavirus/COVID-19 ,
DEA ,
Department of Health and Human Services (HHS) ,
Department of Justice (DOJ) ,
HDHP ,
Health Care Providers ,
Health Insurance ,
Health Savings Accounts ,
Medicaid ,
Medicare ,
Public Health Emergency ,
Rural Health Care Providers ,
Telehealth
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
...more
3/30/2023
/ Biden Administration ,
Center for Biologics Evaluation and Research (CBER) ,
Centers for Medicare & Medicaid Services (CMS) ,
Children's Health Insurance Program (CHIP) ,
Congressional Committees ,
Congressional Investigations & Hearings ,
Coronavirus/COVID-19 ,
Drug Pricing ,
Families First Coronavirus Response Act (FFCRA) ,
Health Care Providers ,
HRSA ,
Medicaid ,
Organ Transplant Centers ,
Pharmacy Benefit Manager (PBM) ,
Prescription Drugs ,
Public Health Emergency ,
Public Policy ,
Secretary of HHS
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
This week's topics include...more
2/9/2023
/ Biden Administration ,
Centers for Medicare & Medicaid Services (CMS) ,
Congressional Investigations & Hearings ,
Coronavirus/COVID-19 ,
Department of Health and Human Services (HHS) ,
Federal Budget ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Medicaid ,
Medicare ,
New Guidance ,
Pending Legislation ,
Pharmacies ,
Public Health Emergency ,
Section 340B ,
State of the Union
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
This week's topics include: ...more
1/19/2023
/ Centers for Medicare & Medicaid Services (CMS) ,
Congressional Committees ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Graduate Medical Education ,
Health Care Providers ,
MACPAC ,
Medicaid ,
Medicare ,
Medicare Part D ,
MedPAC ,
Public Health Emergency
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
This week's topics include . . ....more
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
This week's topics include: ...more
12/15/2022
/ Centers for Medicare & Medicaid Services (CMS) ,
Continuing Resolution ,
Federal Funding ,
Federally Facilitated Exchanges ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Innovation ,
International Standards ,
Legislative Agendas ,
Medicaid ,
Medicare ,
New Guidance ,
Physician Medicare Reimbursements ,
Prior Authorization ,
Proposed Rules
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
This week's topics include:
-...more
12/7/2022
/ Affordable Care Act ,
Centers for Medicare & Medicaid Services (CMS) ,
Congressional Committees ,
Continuing Resolution ,
Dispute Resolution ,
Health Care Providers ,
Legislative Agendas ,
Medicaid ,
Medicare ,
Mental Health ,
Prescription Drugs ,
Proposed Legislation ,
Section 340B